Clinical Trial Update: A Study Evaluating Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade for Limited-stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating concurrent chemoradiotherapy with dual immune checkpoint blockade for limited-stage small cell lung cancer; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Small-Cell Lung Cancer (SCLC) | Phase 2 | Status: NOT_YET_RECRUITING